Showing 3601-3610 of 5621 results for "".
- Perry J. Sternberg Joins Sydnexis as Chief Executive Officerhttps://modernod.com/news/perry-j-sternberg-joins-sydnexis-as-chief-executive-officer/2482358/Sydnexis has announced the appointment of Perry J. Sternberg as Chief Executive Officer and a member of the Board of Directors. Mr. Sternberg is a pharma/biotech executive with more than 30 years in the industry and 15 years in eye care. Immediately prior to joining Sydnexis,
- Claes H. Dohlman, MD, Cornea Research Pioneer and Visionary, Passes Away at 101https://modernod.com/news/claes-h-dohlman-md-cornea-research-pioneer-and-visionary-passes-away-at-101/2482356/Cornea Research Pioneer Claes H. Dohlman, MD, PhD, professor of Ophthalmology, Emeritus, and former Chief and Chair of the Department of Ophthalmology at Mass Eye and Ear and Harvard Medical School (HMS), passed away at the age of 101 on July 14, 2024, Mass Eye and Ear announced on Monday.
- Mount Sinai Ophthalmologists Present New Research at ASRShttps://modernod.com/news/mount-sinai-ophthalmologists-present-new-research-at-asrs/2482355/Ophthalmologists from New York Eye and Ear Infirmary of Mount Sinai in New York City have prepared the following research for the ASRS annual meeting in Stockholm, Sweden, July 17-20. FOUNDERS AWARD WINNER LECTURE Jammi
- Okyo Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101https://modernod.com/news/okyo-pharma-to-initiate-neuropathic-corneal-pain-trial-for-ok-101/2482353/Okyo Pharma announced its plan to advance OK-101 into a phase 2 clinical trial of neuropathic corneal pain which is expected to begin in Q3 2024. This 1-year study is supported by preclinical animal model data and statistically significant pain relief observe
- Hospital in Poland is First Teaching Institution to Use Haag-Streit's Eyesi Indirect Ophthalmoscope ROP Simulatorshttps://modernod.com/news/hospital-in-poland-is-first-teaching-institution-to-use-haag-streits-eyesi-indirect-ophthalmoscope-rop-simulators/2482352/Haag-Streit announced it has enabled trainee ophthalmologists across Poland to become competent in the skills required for effective ROP examination in a lifelike, yet risk-free, environment. The University Clinical Hospital, Poland, will be the first teaching institution globally to use four Eye
- Genentech to Reintroduce Susvimo Ocular Implant for Wet AMDhttps://modernod.com/news/genentech-to-reintroduce-susvimo-for-wet-amd/2482347/Following the end of a voluntary recall, Genentech said it is reintroducing Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the treatment of wet age-related macular degeneration (AMD). The decision c
- B+L Shares Dry Eye Survey Results and Launches Awareness Campaignhttps://modernod.com/news/bl-shares-dry-eye-survey-results-and-launches-awareness-campaign/2482346/Bausch + Lomb shared results from its 'State of Dry Eye' survey, which aimed to explore dry eye understanding and experiences among adults in the US. The research was conducted online by The Harris Poll on behalf of Bausch + Lomb among 2,003 U.S. adults 18 years o
- PharmAbcine Advances Phase 1 Clinical Trial of PMC-403 for nAMDhttps://modernod.com/news/pharmabcine-advances-phase-1-clinical-trial-of-pmc-403-for-namd/2482343/PharmAbcine, Inc., a South Korea-based clinical-stage developer of medical therapeutics, announced the Safety Review Committee (SRC) approval of single 3-mg dose for the third cohort in phase 1 clinical trial of PMC-403, the company&rsquo
- FDA Approves Genentech’s Vabysmo Prefilled Syringe for AMD, DME, and RVOhttps://modernod.com/news/genentechs-vabysmo-prefilled-syringe-approved-by-fda-for-amd-dme-and-rvo/2482342/Genentech announced FDA approval of Vabysmo (faricimab-svoa) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of wet age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema after retinal vein occlusion (RVO). The company advised that Vabysmo
- NEI Funded Study Reveals Neural Mechanism of Encoding Familiar Faceshttps://modernod.com/news/nei-funded-study-reveals-neural-mechanism-of-encoding-familiar-faces/2482335/National Eye Institute funded research at University of Tsukuba demonstrated that faces of familiar individuals with whom one has frequent social interactions with are learned in the basal ganglia region through the same neural mechanisms that recognize the value of objects.